Drug compounders sue over weight loss drugs' removal from FDA shortage list

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug shortage list. Last week, the FDA officially moved Ozempic and Wegovy off its shortage list four months after the drug was found to available in the U.S....